Recurrent breast cancer treated successfully with mitomycin-C and vinblastine after failure of both doxorubicin-containing regimen and paclitaxel - a case report

Tohoku Journal of Experimental Medicine

Volumn 178, Issue 3, 1996, Pages 331-337

  Sekine, Ikuo ^a   Sasaki, Yasutsuna ^a   Fujii, Hirobumi ^a   Ohtsu, Tomoko ^a   Wakita, Hisashi ^a   Igarashi, Tadahiko ^a   Itoh, Kuniaki ^a   Abe, Kaoru ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

drug resistance; microtubule inhibitor; salvage; second line

Indexed keywords

CYCLOPHOSPHAMIDE; DOXIFLURIDINE; DOXORUBICIN; FLUOROURACIL; MEDROXYPROGESTERONE ACETATE; METHOTREXATE; MITOMYCIN C; PACLITAXEL; TAMOXIFEN; VINBLASTINE;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; CROSS RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION;

ADENOCARCINOMA, SCIRRHOUS; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; BREAST NEOPLASMS; DOXORUBICIN; FEMALE; HUMANS; MITOMYCIN; PACLITAXEL; RECURRENCE; TREATMENT FAILURE; VINBLASTINE;

EID: 0029916262     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.178.331     Document Type: Article

References (22)

1. Brambilla, C., Zambetti, M., Ferrari, L. & Bonadonna, G. (1989) Mitomycin C and vinblastine in advanced refractory breast cancer. Tumori, 75, 141-144.
2. Denefrio, J.M., East, D.R., Troner, M.B. & Vogel, C.L. (1978) Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy. Cancer Treat. Rep., 62, 2113-2115.
3. Garewal, H.S. (1988) Mitomycin C in the chemotherapy of advanced breast cancer. Semin. Oncol., 15, Suppl. 4, 74-79.
4. Garewal, H.S., Brooks, R.J., Jones, S.E. & Miller, T.P. (1983) Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine. J. Clin. Oncol., 1, 772-775.
5. Haller, D.G., Fox, K.R. & Schuchter, L.M. (1991) Metastatic breast cancer. In: Breast Cancer Treatment, Mosby Year Book, St. Luis, pp. 403-455.
6. Konits, P.H., Aisner, J., van Echo, D.A., Lichtenfeld, K. & Wiernik, P.H. (1981) Mitomycin C and vinblastine chemotherapy for advanced breast cancer. Cancer, 48, 1295-1298.
7. Kosmidis, P.A., Kondylis, D.K. & Lissaios, B. (1990) Salvage chemotherapy for breast cancer patients treated with adjuvant adriamycin-containing regimen. Oncology, 47, 1-3.
8. Koyama, H., Inaji, H., Noguchi, S. & Motomura, K. (1993) Pathophysiology and treatment of recurrent breast cancer. In: Breast Cancer, Medical View, Tokyo, pp. 134-137.
9. Legha, S.S. (1985) A review of mitomycin regimens in advanced breast cancer therapy. Clin. Ther., 7, 286-307.
10. Miura, S. (1993) Clinical statistics in Japan: Carcinoma of the breast. Nippon Rinsho, 51, Suppl., 702-712.
11. Navarro, M.; Bellmunt, J., Balana, C., Colomer, R., Jolis, L. & del Campo, J.M. (1989) Mitomycin C and vinblastine in advanced breast cancer. Oncology, 46, 137-142.
12. Pasterz, R.B., Buzdar, A.U., Hortobagyi, G.N. & Blumenschein, G.R. (1985) Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy. Cancer, 56, 2381-2384.
13. Pierga, J.Y., Spielmann, M., Bertaud, P., Chevalier, T.L.E., Mezlint, A., Guillot, T., Theodore, C. & Tursz, T. (1989) Chemotherapy salvage with elliotinum (E)-mitomycin (M)+VP16 (V) or vinblastine (VLB) in advanced breast cancer. Breast Cancer Res. Treat., 14, 144.
14. Radford, J.A., Knight, R.K. & Rubens, R.D. (1985) Mitomycin C and vinblastine in the treatment of advanced breast cancer. Eur. J. Clin. Oncol., 21, 1475-1477.
15. Rowinsky, E.K., Cazenave, L.A. & Donehower, R.C. (1990) Taxol: A novel investigational antimicrotuble agent. J. Natl. Cancer Inst., 82, 1247-1259.
16. Scheithauer, W., Kornek, G., Haider, K., Kwasny, W., Schenk, T., Pirker, R. & Depisch, D. (1993) Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C. Breat Cancer Res. Treat., 26, 49-53.
17. Sedlacek, S.M. (1993) First-line and salvage therapy of metastatic breast cancer with mitomycin/vinblastine. Oncology, 50, Suppl. 1, 16-23.
18. Seidman, A.D., Reichman, B.S., Crown, J.P., Yao, T.J., Currie, V., Hakes, T.B., Hudis, C.A., Gilewski, T.A., Baselga, J., Forsythe, P., Lepore, J., Mark, L., Fain, K., Souhrada, M., Onetto, N., Arbuck, S. & Norton, L. (1995) Paclitaxel as second and subsequent therapy for metastatic breast cancer: Activity independent of prior anthracycline response. J. Clin. Oncol., 13, 1152-1159.
19. Statistics and Information Department (1994) Trends of death rates from malignant neoplasms by sex, age and site. In: Vital Statistics of Japan 1994, Ministry of Health and Welfare, Tokyo, in press
20. Veronesi, A., Tirelli, U., Galligioni, E., Travo, M.G., Crivellari, D., Magrl, M.D., Roncadin, M., Tumolo, S. & Grigoletto, E. (1982) Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: A pilot study. Cancer Treat. Rep., 66, 559-561.
21. Yusa, K., Sato, W., Yamazaki, A., Tsukahara, S. & Tsuruo, T. (1991) Cross-resistance of human multidrug-resistant cells to mitomycin C. Anticancer Res., 11, 1301-1304.
22. Zaniboni, A., Montini, E., Simoncini, E., Marpicati, P., Arcangeli, G., Meriggi, F. & Marni, G. (1990) Mitomycin-C, vinblastine, and lonidamine as salvage treatment of advanced breast cancer. Am. J. Clin. Oncol., 13, 520-523.